Assessing the Likelihood and Magnitude of a Population Health Benefit Following the Market Introduction of a Modified-Risk Tobacco Product: Enhancements to the Dynamic Population Modeler, DPM(+1)

Risk Analysis

Volumn 38, Issue 1, 2018, Pages 151-162

  Bachand, Annette M ^a   Sulsky, Sandra I ^a   Curtin, Geoffrey M ^b  

^a ENVIRON INTERNATIONAL CORPORATION   (United States)

^b RAI Services Company   (United States)

Author keywords

Population simulation; smoking attributable mortality; tobacco harm reduction policy

Indexed keywords

HEALTH RISKS; RISK ASSESSMENT; RISK PERCEPTION;

CIGARETTE SMOKERS; CUMULATIVE EFFECTS; DYNAMIC POPULATION; HARM REDUCTION; MARKET INTRODUCTION; POPULATION SIMULATION; SMOKING-ATTRIBUTABLE MORTALITY; UNINTENDED CONSEQUENCES;

TOBACCO;

HEALTH POLICY; HEALTH RISK; LIFE EXPECTANCY; MORTALITY; POLLUTION EXPOSURE; POPULATION MODELING; PUBLIC HEALTH; RISK ASSESSMENT; SIMULATION; SMOKING; SURVIVAL; TOBACCO;

NICOTIANA TABACUM;

ADULT; ADULTHOOD; ALL CAUSE MORTALITY; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTINUING SMOKER; CONTROLLED STUDY; HARM REDUCTION; HUMAN; LIFE EXPECTANCY; POPULATION HEALTH; QUALITY OF LIFE; RISK ASSESSMENT; SIMULATION; SMOKING;

EID: 85018925044     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/risa.12819     Document Type: Article

References (23)

1. Bachand AM, Sulsky SI. A dynamic population model for estimating all-cause mortality due to lifetime exposure history. Regulatory Toxicology and Pharmacology, 2013; 67(2):246–251.
2. Jia H, Lubetkin EI. The statewide burden of obesity, smoking, low income and chronic diseases in the United States. Journal of Public Health (Oxford), 2009; 31(4):496–505.
3. Jia H, Zack MM, Thompson WW. State quality-adjusted life expectancy for U.S. adults from 1993 to 2008. Quality of Life Research, 2011; 20(6):853–863.
4. Family Smoking Prevention and Tobacco Control Act. Public Law 111-31 (H.R.1256), 2009.
5. FDA. Modified Risk Tobacco Product Applications: Draft Guidance for Industry. Silver Spring, MD: Center for Tobacco Products, Food and Drug Administration, March 2012. Available at: http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm297750.htm, Accessed March 30, 2017.
6. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, Vienna, Austria, 2015. Available at: http://www.R-project.org/, Accessed March 30, 2017.
7. Stiefel MC, Perla RJ, Zell BL. A healthy bottom line: Healthy life expectancy as an outcome measure for health improvement efforts. Milbank Quarterly, 2010; 88(1):30–53.
8. Madans J. Healthy Life Expectancy, 2012. Available at: http://www.cdc.gov/nchs/ppt/nchs2012/SS-24_MADANS.pdf, Accessed March 30, 2017.
9. Weinstein MC, Torrance G, McGuire A. QALYs: The basics. Value in Health, 2009; 12(s1):S5–S9.
10. Fleishman JA. Methodology Report #15: Demographic and Clinical Variations in Health Status. Rockville, MD: Agency for Healthcare Research and Quality, January 2005. Available at: http://meps.ahrq.gov/data_files/publications/mr15/mr15.shtml, Accessed March 30, 2017.
11. Group E. About EQ-5D, 2014. Available at: http://www.euroqol.org/about-eq-5d.html, Accessed March 30, 2017.
12. Friedman G, Tekawa I, Sadler M, Sidney S. Smoking and mortality: The Kaiser Permanente Experience. Pp. 477–499 in Shopland DR, Burns DM, Garfinkel L, Samet JN (eds). Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1997.
13. U.S. National Center for Health Statistics, Vital Statistics of the United States, U.S. Death and Death Rates, by Age and Leading Cause, 2000. Available at: http://www.allcountries.org/uscensus/129_death_and_death_rates_by_age.html, Accessed March 30, 2017.
14. SAMHSA. NSDUH 2010. Table 4.3B: Past Year Initiation of Cigarette Use among Persons Aged 12 or Older, Persons Aged 12 or Older at Risk for Initiation of Cigarette Use, and Past Year Cigarette Users Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands and Percentages. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2009 and 2010. Available at: http://www.samhsa.gov/data/NSDUH/2K10ResultsTables/NSDUHTables2010R/HTM/Sect4peTabs1to16.htm#Tab4.3B, Accessed March 30, 2017.
15. SAMHSA. Recent Smoking Cessation. Rockville, MD: Substance Abuse and Mental Health Services Administration, April 8, 2010. Available at: http://www.samhsa.gov/data/2k10/172/172smokingcessation.htm, Accessed March 30, 2017.
16. Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino G, Hyland A, Sweanor D, Warner KE. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: Estimates of a panel of experts. Cancer Epidemiology and Prevention Biomarkers, 2004; 13(12):2035–2042.
17. SAMHSA. Results from the 2008 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2009. Available at: http://archive.samhsa.gov/data/NSDUH/2k8nsduh/2k8Results.htm, Accessed March 30, 2017.
18. Feenstra TL, van Baal PHM, Hoogenveen RT, Vijgen SMX, Stolk E, Bemelmans WJE. Cost-Effectiveness of Interventions to Reduce Tobacco Smoking in the Netherlands. An Application of the RIVM Chronic Disease Model. BA Bilthoven. RIVM report, 260601003. The Netherlands: National Institute for Public Health and the Environment, Ministry of Health, Welfare and Sport, 2005.
19. Wagener DK, Molla MT, Crimmins EM, Pamuk E, Madans JH. Summary Measures of Population Health: Addressing the First Goal of Healthy People, 2010, Improving Health Expectancy. Healthy People, 2010. Statistical Notes: from the Centers for Disease Control and Prevention/National Center for Health Statistics. 22, pp. 1–13. Atlanta, GA: Centers for Disease Control and Prevention/National Center for Health Statistics, 2001.
20. Weitkunat R, Lee PN, Baker G, Sponsiello-Wang Z, Gonzalez-Zuloeta Ladd AM, Lüdicke F. A novel approach to assess the population health impact of introducing a modified risk tobacco product. Regulatory Toxicology and Pharmacology, 2015; 72(1):87–93.
21. Vugrin ED, Rostron BL, Verzi SJ, Brodsky NS, Brown TJ, Choiniere CJ, Coleman BN, Paredes A, Apelberg BJ. Modeling the potential effects of new tobacco products and policies: A dynamic population model for multiple product use and harm. PLoS One, 2015; 10(3):e0121008.
22. Poland B, Teischinger F. Population Modeling of Modified Risk Tobacco Products Accounting for Effects of Cigarettes per Day. Chicago, IL: Poster, Society for Research on Nicotine & Tobacco Annual Meeting, 2016.
23. Bachand AM, Sulsky SI. Predicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance. Recent Advances in Tobacco Science, 2016; 42:9–22.